133 related articles for article (PubMed ID: 10448967)
1. Cyclic and linear bradykinin analogues: implications for B2 antagonist design.
Hsieh KH; Stewart JM
J Pept Res; 1999 Jul; 54(1):23-31. PubMed ID: 10448967
[TBL] [Abstract][Full Text] [Related]
2. Synthesis and biological activities of new side chain and backbone cyclic bradykinin analogues.
Schumann C; Seyfarth L; Greiner G; Paegelow I; Reissmann S
J Pept Res; 2002 Aug; 60(2):128-40. PubMed ID: 12102726
[TBL] [Abstract][Full Text] [Related]
3. Peptide and non-peptide bradykinin B2 receptor agonists and antagonists: a reappraisal of their pharmacology in the guinea-pig ileum.
Meini S; Patacchini R; Lecci A; Quartara L; Maggi CA
Eur J Pharmacol; 2000 Dec; 409(2):185-94. PubMed ID: 11104833
[TBL] [Abstract][Full Text] [Related]
4. In vitro and in vivo effects of the new nonpeptide bradykinin B2 receptor antagonist, LF 16-0335C, on guinea-pig and rat kinin receptors.
Pruneau D; Luccarini JM; Fouchet C; Defrêne E; Franck RM; Loillier B; Duclos H; Robert C; Cremers B; Bélichard P; Paquet JL
Fundam Clin Pharmacol; 1999; 13(1):75-83. PubMed ID: 10027091
[TBL] [Abstract][Full Text] [Related]
5. Bradykinin receptor types and B2 subtypes.
Regoli D; Gobeil F; Nguyen QT; Jukic D; Seoane PR; Salvino JM; Sawutz DG
Life Sci; 1994; 55(10):735-49. PubMed ID: 8072371
[TBL] [Abstract][Full Text] [Related]
6. Characterization of non-peptide bradykinin B2 receptor agonist (FR 190997) and antagonist (FR 173657).
Gobeil F; Montagne M; Inamura N; Regoli D
Immunopharmacology; 1999 Sep; 43(2-3):179-85. PubMed ID: 10596851
[TBL] [Abstract][Full Text] [Related]
7. New agonist and antagonist analogues of bradykinin.
Barabé J; Caranikas S; D'Orléans-Juste P; Regoli D
Can J Physiol Pharmacol; 1984 Jun; 62(6):627-9. PubMed ID: 6146395
[TBL] [Abstract][Full Text] [Related]
8. Bradykinin B2 receptors and coupling mechanisms in the smooth muscle of the guinea-pig taenia caeci.
Field JL; Butt SK; Morton IK; Hall JM
Br J Pharmacol; 1994 Oct; 113(2):607-13. PubMed ID: 7834214
[TBL] [Abstract][Full Text] [Related]
9. The longitudinal muscle of rat ileum as a sensitive monoreceptor assay for bradykinin B1 receptors.
Meini S; Lecci A; Maggi CA
Br J Pharmacol; 1996 Apr; 117(8):1619-24. PubMed ID: 8732268
[TBL] [Abstract][Full Text] [Related]
10. Agonist activity at the kinin B1 receptor: structural requirements of the central tetrapeptide.
Rovero P; Pellegrini M; Di Fenza A; Meini S; Quartara L; Maggi CA; Formaggio F; Toniolo C; Mierke DF
J Med Chem; 2001 Jan; 44(2):274-8. PubMed ID: 11170638
[TBL] [Abstract][Full Text] [Related]
11. Pharmacological characterization of a nonpeptide bradykinin B2 receptor antagonist, FR165649, and agonist, FR190997.
Asano M; Hatori C; Sawai H; Johki S; Inamura N; Kayakiri H; Satoh S; Abe Y; Inoue T; Sawada Y; Mizutani T; Oku T; Nakahara K
Br J Pharmacol; 1998 Jun; 124(3):441-6. PubMed ID: 9647466
[TBL] [Abstract][Full Text] [Related]
12. Design and synthesis of potent bradykinin agonists containing a benzothiazepine moiety.
Amblard M; Daffix I; Bedos P; Bergé G; Pruneau D; Paquet JL; Luccarini JM; Bélichard P; Dodey P; Martinez J
J Med Chem; 1999 Oct; 42(20):4185-92. PubMed ID: 10514288
[TBL] [Abstract][Full Text] [Related]
13. Bradykinin antagonists with dehydrophenylalanine analogues at position 5.
Greiner G; Dornberger U; Paegelow I; Schölkens BA; Liebmann C; Reissmann S
J Pept Sci; 1998 Apr; 4(2):92-100. PubMed ID: 9620613
[TBL] [Abstract][Full Text] [Related]
14. [Arg1-D-Phe7]-substituted bradykinin analogs inhibit bradykinin- and vasopressin-induced contractions of uterine smooth muscle.
Farmer SG; Burch RM; Dehaas CJ; Togo J; Steranka LR
J Pharmacol Exp Ther; 1989 Feb; 248(2):677-81. PubMed ID: 2537408
[TBL] [Abstract][Full Text] [Related]
15. Competitive antagonists of bradykinin.
Vavrek RJ; Stewart JM
Peptides; 1985; 6(2):161-4. PubMed ID: 4034408
[TBL] [Abstract][Full Text] [Related]
16. Bradykinin competitive antagonists for classical kinin systems.
Stewart JM; Vavrek RJ
Adv Exp Med Biol; 1986; 198 Pt A():537-42. PubMed ID: 3812091
[TBL] [Abstract][Full Text] [Related]
17. Hoe 140 a new potent and long acting bradykinin-antagonist: in vitro studies.
Hock FJ; Wirth K; Albus U; Linz W; Gerhards HJ; Wiemer G; Henke S; Breipohl G; König W; Knolle J
Br J Pharmacol; 1991 Mar; 102(3):769-73. PubMed ID: 1364851
[TBL] [Abstract][Full Text] [Related]
18. Structure-activity studies of bradykinin and related peptides. B2-receptor antagonists.
Rhaleb NE; Télémaque S; Rouissi N; Dion S; Jukic D; Drapeau G; Regoli D
Hypertension; 1991 Jan; 17(1):107-15. PubMed ID: 1846119
[TBL] [Abstract][Full Text] [Related]
19. In vitro and in vivo activity of analogues of the kinin B2 receptor antagonist MEN1 1270.
Meini S; Lecci A; Carini F; Tramontana M; Giuliani S; Maggi CA; Ricci R; Fabbri G; Anichini B; Harmat N; Rizzi A; Camarda V; Regoli D; Quartara L
Can J Physiol Pharmacol; 2002 Apr; 80(4):293-302. PubMed ID: 12025964
[TBL] [Abstract][Full Text] [Related]
20. Pharmacological characterization of canine bradykinin receptors in prostatic culture and in isolated prostate.
Srinivasan D; Burbach LR; Daniels DV; Ford AP; Bhattacharya A
Br J Pharmacol; 2004 May; 142(2):297-304. PubMed ID: 15155537
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
